Its become foundational to how we practice medicine and deliver care. Big disparities GLP-1 drugs were introduced to manage blood sugar in patients with type 2 diabetes, beginning with the approval of Byetta in 2005, followed by Ozempic in 2017 and Mounjaro in 2024
There is no difference in glucose reduction compared to the add-on of GLP1-RAs first or the SGLT2is first
Journal of Biological Chemistry, 250(4), 1422-1426
When it comes to dogs, small-animal obesity expert Alex German recently told the Telegraph that new pet-friendly Ozempic-style drugs would succeed as a preventative measure instead of treating existing conditions like diabetes
doi: 10.1155/2016/9043450 76 ErnstFRSandulliWElmorRWelsteadJStermanABLavanM
With friendly support and expert direction, our team makes it easier for Kentuckians to take control of their health